320 related articles for article (PubMed ID: 26596048)
1. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
[TBL] [Abstract][Full Text] [Related]
2. Chemokine Receptors CXCR3 and CCR6 and Their Ligands in the Liver and Blood of Patients with Chronic Hepatitis C.
Arsent'eva NA; Semenov AV; Lyubimova NE; Ostankov YV; Elezo DS; Kudryavtsev IV; Basina VV; Esaulenko EV; Kozlov KV; Zhdanov KV; Totolyan AA
Bull Exp Biol Med; 2015 Dec; 160(2):252-5. PubMed ID: 26631389
[TBL] [Abstract][Full Text] [Related]
3. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection.
Chalin A; Lefevre B; Devisme C; Barget N; Amiot L; Samson M
Cytokine; 2019 May; 117():72-78. PubMed ID: 30826602
[TBL] [Abstract][Full Text] [Related]
5. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
6. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.
Magri MC; Alvarez MSM; Iogi AA; Alves GM; Manchiero C; Dantas BP; Prata TVG; Nunes AKDS; Tengan FM
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33476381
[TBL] [Abstract][Full Text] [Related]
7. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C.
Radmanić L; Šimičić P; Bodulić K; Vince A; Zidovec-Lepej S
Cytokine; 2024 Apr; 176():156529. PubMed ID: 38335772
[TBL] [Abstract][Full Text] [Related]
8. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.
Yin X; Wang Z; Wu T; Ma M; Zhang Z; Chu Z; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
J Transl Med; 2019 Dec; 17(1):417. PubMed ID: 31836011
[TBL] [Abstract][Full Text] [Related]
9. A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.
Florholmen J; Kristiansen MG; Steigen SE; Sørbye SW; Paulssen EJ; Kvamme JM; Konopski Z; Gutteberg T; Goll R
Clin Microbiol Infect; 2011 Feb; 17(2):204-9. PubMed ID: 20219081
[TBL] [Abstract][Full Text] [Related]
10. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
[TBL] [Abstract][Full Text] [Related]
11. Chemokine profile in women with moderate to severe anxiety and depression during pregnancy.
Camacho-Arroyo I; Flores-Ramos M; Mancilla-Herrera I; Cruz FMC; Hernández-Ruiz J; Diaz GP; Labonne BF; Del Pilar Meza-Rodríguez M; Gelman PL
BMC Pregnancy Childbirth; 2021 Dec; 21(1):807. PubMed ID: 34863117
[TBL] [Abstract][Full Text] [Related]
12. CXCL9, a promising biomarker in the diagnosis of chronic Q fever.
Jansen AFM; Schoffelen T; Textoris J; Mege JL; Nabuurs-Franssen M; Raijmakers RPH; Netea MG; Joosten LAB; Bleeker-Rovers CP; van Deuren M
BMC Infect Dis; 2017 Aug; 17(1):556. PubMed ID: 28793883
[TBL] [Abstract][Full Text] [Related]
13. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
14. Predominant interferon-γ-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis.
Wen X; Kudo T; Payne L; Wang X; Rodgers L; Suzuki Y
J Interferon Cytokine Res; 2010 Sep; 30(9):653-60. PubMed ID: 20626297
[TBL] [Abstract][Full Text] [Related]
15. Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.
Zeremski M; Hooker G; Shu MA; Winkelstein E; Brown Q; Des Jarlais DC; Tobler LH; Rehermann B; Busch MP; Edlin BR; Talal AH
J Hepatol; 2011 Sep; 55(3):545-553. PubMed ID: 21256906
[TBL] [Abstract][Full Text] [Related]
16. A correlation study between gene polymorphism of Th cell expressed chemokine receptor CXCR3 and its ligand levels with HCV infection prognosis.
Lu Y; Lin LY; Tan JG; Deng HP; Li XH; Zhang Z; Li Y; Zhou Z; Xu X; Xie X; Mei SJ
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1290-1295. PubMed ID: 28387899
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
[TBL] [Abstract][Full Text] [Related]
18. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients.
Pineda-Tenor D; Berenguer J; Jiménez-Sousa MA; Guzmán-Fulgencio M; Aldámiz-Echevarria T; Carrero A; García-Álvarez M; Diez C; Tejerina F; Briz V; Resino S
J Clin Virol; 2014 Nov; 61(3):423-9. PubMed ID: 25218243
[TBL] [Abstract][Full Text] [Related]
19. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.
Zeremski M; Dimova R; Astemborski J; Thomas DL; Talal AH
J Infect Dis; 2011 Sep; 204(6):832-6. PubMed ID: 21849280
[TBL] [Abstract][Full Text] [Related]
20. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
